Chimera builds safer and more powerful CAR T cancer therapies with control. Our switches turn any CAR into a controllable CAR, like a therapeutic API. We engage in partnerships with the rapidly growing CAR T biopharma industry which yield co-development, milestone and royalty based revenues.